189 related articles for article (PubMed ID: 32776411)
1. Long-term outcomes in patients with recurrent human papillomavirus-positive oropharyngeal cancer after upfront transoral robotic surgery.
Su W; Rajeev-Kumar G; Kang M; Posner M; Liu JT; Westra W; Miles BA; Gupta V; Sharma S; Misiukiewicz K; Genden E; Bakst RL
Head Neck; 2020 Dec; 42(12):3490-3496. PubMed ID: 32776411
[TBL] [Abstract][Full Text] [Related]
2. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Funk RK; Moore EJ; García JJ; Harmsen WS; Stoddard DG; Vencio EF; Foote RL; Price KA; Ma DJ
Head Neck; 2016 Apr; 38 Suppl 1():E1674-9. PubMed ID: 26667985
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
[TBL] [Abstract][Full Text] [Related]
5. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
6. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
[TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
[TBL] [Abstract][Full Text] [Related]
8. HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery.
Kaczmar JM; Tan KS; Heitjan DF; Lin A; Ahn PH; Newman JG; Rassekh CH; Chalian AA; O'Malley BW; Cohen RB; Weinstein GS
Head Neck; 2016 Jan; 38(1):59-65. PubMed ID: 25197014
[TBL] [Abstract][Full Text] [Related]
9. A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
Brody RM; Shimunov D; Cohen RB; Lin A; Lukens JN; Hartner L; Aggarwal C; Duvvuri U; Montone KT; Jalaly JB; LiVolsi VA; Carey RM; Shanti RM; Rajasekaran K; Chalian AA; Rassekh CH; Cannady SB; Newman JG; O'Malley BW; Weinstein GS; Gimotty PA; Basu D
Oral Oncol; 2022 Apr; 127():105798. PubMed ID: 35245888
[TBL] [Abstract][Full Text] [Related]
10. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
11. Impact of human papillomavirus and smoking on survival outcomes after transoral robotic surgery.
Stucken CL; de Almeida JR; Sikora AG; Tong CC; Genden EM
Head Neck; 2016 Mar; 38(3):380-6. PubMed ID: 25351893
[TBL] [Abstract][Full Text] [Related]
12. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
13. De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.
Miles BA; Posner MR; Gupta V; Teng MS; Bakst RL; Yao M; Misiukiewicz KJ; Chai RL; Sharma S; Westra WH; Kim-Schulze S; Dayal B; Sobotka S; Sikora AG; Som PM; Genden EM
Oncologist; 2021 Jun; 26(6):504-513. PubMed ID: 33675133
[TBL] [Abstract][Full Text] [Related]
14. Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review.
Dowthwaite S; Jackson J; Dzienis M; Khoo E; Cronin M; Guazzo E
Curr Oncol Rep; 2023 May; 25(5):501-510. PubMed ID: 36881215
[TBL] [Abstract][Full Text] [Related]
15. Upfront transoral robotic surgery (TORS)
Zorzi SF; Agostini G; Chu F; Tagliabue M; Pietrobon G; Corrao G; Volpe S; Marvaso G; Colombo F; Cossu Rocca M; Gandini S; Gaeta A; Ruju F; Alterio D; Ansarin M
Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):334-347. PubMed ID: 35938555
[TBL] [Abstract][Full Text] [Related]
16. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
17. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System.
Faraji F; Kumar A; Voora R; Soliman SI; Cherry D; Courtney PT; Finegersh A; Guo T; Cohen E; Califano JA; Mell L; Rose B; Orosco RK
Laryngoscope; 2024 Jan; 134(1):207-214. PubMed ID: 37255050
[TBL] [Abstract][Full Text] [Related]
18. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
Holcomb AJ; Herberg M; Strohl M; Ochoa E; Feng AL; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Sadow P; Faquin W; Faden D; Deschler DG; Varvares MA; Lin DT; Fakhry C; Ryan WR; Richmon JD
Head Neck; 2021 Aug; 43(8):2434-2444. PubMed ID: 33856083
[TBL] [Abstract][Full Text] [Related]
19. Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
Bollig CA; Morris B; Stubbs VC
Head Neck; 2022 Jul; 44(7):1545-1553. PubMed ID: 35365915
[TBL] [Abstract][Full Text] [Related]
20. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
